ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer
Supportive Care in Cancer
◽
10.1007/s00520-008-0558-2
◽
2009
◽
Vol 17
(8)
◽
pp. 1081-1088
◽
Cited By ~ 7
Author(s):
Lee S. Schwartzberg
◽
Patrick Cobb
◽
Mark S. Walker
◽
Edward J. Stepanski
◽
Arthur C. Houts
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Second Line
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
Related Documents
Cited By
References
Abstract PS13-31: Prospective observational study to explore the effectiveness of eribulin as first- or second- line chemotherapy in patients with HER2-negative hormone-resistant advanced or metastatic breast cancer (KBCRN A001: E-SPEC study)
10.1158/1538-7445.sabcs20-ps13-31
◽
2021
◽
Author(s):
Yuri Fujimoto
◽
Yuichiro Kikawa
◽
Takeshi Kotake
◽
Shigeru Tsuyuki
◽
Sachiko Takahara
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Observational Study
◽
Prospective Observational Study
◽
Metastatic Breast
◽
Second Line
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
230 A Phase II Study of Pegylated Liposomal Doxorubicin Combined with Cyclophosphamide / 5-fluorouracil as Second Line Chemotherapy in Patients with Metastatic Breast Cancer Who Failed Previous Taxane-based Treatment
European Journal of Cancer
◽
10.1016/s0959-8049(12)70298-8
◽
2012
◽
Vol 48
◽
pp. S109-S110
Author(s):
H.K. Chang
◽
Y.C. Lin
◽
K.M. Rau
◽
Y.Y. Chen
◽
K.D. Lee
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Study
◽
Metastatic Breast
◽
Pegylated Liposomal Doxorubicin
◽
Second Line
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy
Value in Health
◽
10.1016/j.jval.2014.08.2289
◽
2014
◽
Vol 17
(7)
◽
pp. A637
Author(s):
I. Krysanov
◽
V. Krysanova
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Cost Effectiveness
◽
Metastatic Breast
◽
Cost Effectiveness Analysis
◽
Second Line
◽
Second Line Chemotherapy
◽
Effectiveness Analysis
◽
Line Chemotherapy
Download Full-text
A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
Journal of Cancer Research and Clinical Oncology
◽
10.1007/s00432-007-0259-0
◽
2007
◽
Vol 134
(2)
◽
pp. 125-135
◽
Cited By ~ 9
Author(s):
Martina Baur
◽
Allan T. van Oosterom
◽
Véronique Diéras
◽
Michele Tubiana-Hulin
◽
R. Charles Coombes
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Second Line
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
A phase II, multicenter, single-arm trial of eribulin as first or second line chemotherapy for HER2-negative advanced or metastatic breast cancer: Evaluation of efficacy, safety, and patient-reported outcomes.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.e13059
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. e13059-e13059
◽
Cited By ~ 2
Author(s):
Mitsuhiko Iwamoto
◽
Kosei Kimura
◽
Satoru Tanaka
◽
Daigo Yamamoto
◽
Katsuhide Yoshidome
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Patient Reported Outcomes
◽
Metastatic Breast
◽
Second Line
◽
Second Line Chemotherapy
◽
Patient Reported
◽
Line Chemotherapy
Download Full-text
A Cost-Utility Analysis of Second-Line Chemotherapy in Metastatic Breast Cancer
PharmacoEconomics
◽
10.2165/00019053-199610050-00008
◽
1996
◽
Vol 10
(5)
◽
pp. 504-521
◽
Cited By ~ 57
Author(s):
Robert Launois
◽
Jeanne Reboul-Marty
◽
Bernadette Henry
◽
Jacques Bonneterre
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Cost Utility
◽
Cost Utility Analysis
◽
Second Line
◽
Utility Analysis
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
Abstract P6-11-03: Beyond the Second Line Chemotherapy in Metastatic Breast Cancer: When Stop the Treatment between Science and Conscience
10.1158/0008-5472.sabcs10-p6-11-03
◽
2010
◽
Cited By ~ 1
Author(s):
G Bernardo
◽
R Palumbo
◽
G Poggi
◽
A Bernardo
◽
C Teragni
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Second Line
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
Phase II trial of docetaxel and Herceptin (R) as first- or second-line chemotherapy for women with metastatic breast cancer whose tumours overexpress HER2
European Journal of Cancer
◽
10.1016/s0959-8049(99)81709-2
◽
1999
◽
Vol 35
◽
pp. S322
Author(s):
H.A. Burris
◽
J.D. Hainesworth
◽
K. Albain
◽
M. Huntington
◽
F.A. Greco
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Second Line
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer
Breast Cancer Research and Treatment
◽
10.1023/a:1026360621622
◽
2003
◽
Vol 81
(S1)
◽
pp. 33-36
◽
Cited By ~ 1
Author(s):
Christoph C. Zielinski
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Second Line
◽
Treatment Choices
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
P917. Taxol and fluorouracil as second line chemotherapy for metastatic breast cancer
The Breast
◽
10.1016/s0960-9776(97)90088-6
◽
1997
◽
Vol 6
(5)
◽
pp. 335
Author(s):
A. Fornasiero
◽
C. Ghiotto
◽
O. Daniele
◽
P. D'Amanzo
◽
S.M.L. Aversa
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Second Line
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close